Drug intelligence / Profile preview

nano-luteolin

Development stage
Phase 1
Modality
Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous (most Common In Animal Studies)
01

Overview

Nano-luteolin refers to a class of nanotechnology-based formulations in which the natural flavonoid luteolin is encapsulated or incorporated into nanoscale carriers such as polymeric nanoparticles, nanovesicles, micelles, or other delivery systems. These nanoformulations are designed to overcome the poor water solubility, low bioavailability, and rapid metabolism of free luteolin. By using nanocarriers (e.g., polymers like PEG or phospholipids), nano-luteolin enhances the solubility and stability of luteolin in biological environments and enables targeted delivery to tissues. Mechanistically, these formulations retain the pharmacological activities of luteolin—including anti-inflammatory, antioxidant, anticancer (notably against lung cancer), antibacterial (including activity against bacterial prostatitis), neuroprotective effects—by modulating multiple molecular pathways such as inhibition of PI3K/Akt-mediated NF-κB and MAPK signaling pathways. Nanoformulations have demonstrated improved therapeutic efficacy with reduced cytotoxicity compared to free luteolin in preclinical models[1][2][3][4][5][6].

Other names
polymer-encapsulated luteolin nanoparticlepolyluteolin nanoparticlesluteolin-loaded nanovesiclesLT-NVs
02

Targets

Nuclear factor kappa-light-chain-enhancer of activated B cells p65–CREB-binding protein transcriptional coactivator complexMpro (3C-like proteinase of SARS-CoV-2)

Beyond the preview

Go deeper on nano-luteolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nano-luteolin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call